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Abstract 
This paper discusses the process of identifying stakeholders 
for the evaluation of health information systems through a 
map. Defining the multiplicity of stakeholders associated with 
a new system as well as the nature of their relationships is an 
important aspect of evaluating any intervention. We report a 
study of the Electronic Prescription Service (EPS) in primary 
care in England. We describe the complexity associated with 
the process of identifying stakeholders and illustrating their 
dynamic relationships. Reflecting upon our experience of 
map-making and map-using, we discuss the role of a stake-
holder map to generate and communicate knowledge. The 
EPS stakeholder map – in its variety of possible alternative 
representations – reveals the complexity of the electronic pre-
scribing scenario and the challenge of its evaluation. Recog-
nising the drawbacks of a static two dimensional representa-
tion, we argue that a dynamic use of a stakeholder map and a 
reflective map-making practice is useful and important for the 
evaluation of IT programmes in healthcare.  
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Introduction   
Health information systems are expected to improve the deliv-
ery of healthcare, raise patient satisfaction and support excel-
lent work practices by healthcare professionals. The adoption 
of any health information system will be dependent upon a 
number of different stakeholders including the people who are 
directly or indirectly associated with and affected by it (pa-
tients, nurses, doctors, software developers, IT managers, pro-
duct specialists) and a number of organisations and institutions 
that frame its adoption and functionality (government depart-
ments, regulators, health care institutions, professional bodies, 
technical service providers) [1-3]. Identifying the multiplicity 
of stakeholders associated with a new system as well as the 
nature of their interests and relationships one to another, con-
stitutes an important prerequisite for evaluating any interven-
tion. A powerful means to do this is through the drawing of a 
map, a visual representation of entities and relationships.  
This paper discusses drawing a stakeholder map as part of an 
evaluation study of the Electronic Prescription Service (EPS) 
in primary care in England. EPS is the National Health Serv-
ices (NHS) new system for the electronic transmission of pre-
scriptions. EPS is part of the UK National Programme for IT 
(NPfIT), which is delivered by the Department of Health ag-
ency, Connecting for Health (CfH). One of the main objec-
tives of the EPS is to provide a more efficient and accurate 
NHS prescription service, able to cope with the issuing, dis-
pensing and reimbursement of “around 1.5 million paper pre-
scriptions” per working day [4]. This service is being deliv-
ered over two main releases of software and functionality, and 
our paper draws upon work investigating the introduction of 
the Electronic Prescription Service Release 2 (EPS2).  
Stakeholders are often identified in accordance with their posi-
tion relative to a focal system and/or an organisational posi-
tion. In that way stakeholders may be distinguished, for exam-
ple, as being either ‘internal’ or ‘external’ stakeholders rela-
tive to the owner organization [5]. Stakeholder importance 
may be identified by their power to influence, their legitimacy 
to make decisions, or their right to make claims (perhaps ur-
gent or arbitrary) that have an immediate impact on the focal 
system or on other stakeholders [6]. In conventional maps, 
stakeholders are often depicted as revolving around an organi-
zation or system, and to have unidirectional and simple rela-
tions with it [5] but not with each other. Pouloudi and Whitley 
[3], however, argue that identification of stakeholders is a 
complex and dynamic procedure that requires taking into con-
sideration that stakeholder inter-relationships are important, 
temporally and spatially bound, interdependent, dynamic and 
often conflicting. We contribute to this critical approach by 
discussing the complex nature of stakeholder mapping during 
the identification of stakeholders in EPS2.  
The paper has two aims. First, we explore the complexity as-
sociated with the process of identifying different stakeholders 
and illustrating their dynamic relationships - map making. To 
do so we reflect upon our experience in drawing a stakeholder 
map as a methodological question. Second, we aim to discuss 
the benefits and drawbacks that emanate from using the map 
as an analytical tool - map using. 
An Introduction to EPS2 
At the core of EPS is the electronic transmission of prescrip-
tion messages from prescribing systems, to a secure server - 
the ‘Spine’ - from which the prescription message can be sent 
to, or called by a dispensing contractor of the patient’s choice. 
The service is being introduced into England over two re-
leases. EPS Release 1 (EPS1) introduced and tested the tech-
nical infrastructure, with electronic messages holding copies 
of prescription content supplementing the traditional paper 
prescriptions. In EPS2, launched in 2009, the prescription 
switches to a digitally signed electronic message, offering a 
potentially paperless prescribing and transmission process. 
The prescription is transmitted from the prescriber through the 
Spine enabling the unique identification of patients, and ser-
vice providers (prescriber and dispenser in this case). Access 
to the Spine for digital signing of prescriptions is allowed by 
use of a person specific smartcard, with chip and pin code. 
Software suppliers for prescribers and dispensers are expected 
to independently implement EPS2 compliant functionalities. 
Their systems are then subject to a CfH certification process 
before they can connect to the Spine. Prior to deployment of 
EPS2 prescriber systems in different Primary Care Trusts (the 
purchasers of healthcare for a geographic area), the Secretary 
of State must authorise the issuing of electronic (paperless) 
prescriptions and electronic signatures. This is done area by 
area, making electronic prescriptions legal in England for the 
first time. 
A detailed description of the functioning of EPS compliant 
systems is outside of the scope of this paper. Information can 
be found on the CfH website1.  
Methodology 
The stakeholder mapping for EPS2 was part of a wider project 
aimed at the evaluation of the Electronic Prescription Service. 
The evaluation began while software testing for EPS2 compli-
ant systems was still in progress and EPS1 compliant systems 
were in use. The technology for EPS2 was not available for 
use at the start, but key stakeholders were preparing for initial 
pilots and successive deployments across PCTs in England. 
The data reported here was therefore based on stakeholders’ 
initial experiences with EPS1 (e.g. feedback from pharma-
cists) and expectations for EPS2, plans, prospected problems 
and solutions. The study is based on interviews with a number 
of different groups and organisations including software sup-
pliers for dispensing and prescribing systems, PCTs, com-
munity pharmacies and the Department of Health. Interviews 
were recorded when possible with participants’ consent, and 
transcripts were used for the analysis. Written field notes were 
used when recording was not possible.  
The map – in its successive cyclical revisions - was used dur-
ing these interviews as a starting point for discussing roles and 
relationships of different parties and organisations in the pre-
EPS business model, and in the development, adoption and 
use of EPS. The stakeholder map was (and at the time of writ-
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ing still is) constantly modified and further refined in order to 
reflect participants’ viewpoints.  
Results – Map-Making 
Connecting for Health presents the expected benefits of EPS2 
in terms of benefits for prescribing staff, dispensing staff, pa-
tients and their representatives2. Initially these appear as the 
three primary stakeholders of EPS2 as direct users of the sys-
tem functionality (Fig 1). Prescribers (Pr) (typically General 
Practitioners - GPs) use EPS2 compliant systems for issuing 
prescriptions; patients (or their representatives) (P) use EPS2 
systems to nominate the pharmacies where they wish to col-
lect the prescribed medications; dispensers (D) (typically 
Community Pharmacists) use EPS2 compliant systems to re-
ceive the e-prescriptions, and then dispense and label pro-
ducts, record the dispensed medication and transmit the e-
prescriptions onward to the reimbursement agency (NHS Pre-
scription Services).  
Figure 1. Three stakeholders  -  
direct users of EPS systems 
Reading the official documentation of EPS2 [eg. 4], the reim-
bursement agency could be interpreted as (at least) a secon-
dary stakeholder. Yet, some interviewees thought of the reim-
bursement agency as one of the main beneficiary of a paper-
less system on the grounds that EPS2 would reduce manual 
paper handling and eliminate data entry duplication. Our in-
itial map with the three main users would need to expand and 
include another perhaps less visible beneficiary in the Pre-
scription Services (PS). 
Further analysis of prescribers and dispensers revealed a 
multiplicity of different parties under these broad headings. 
For example, among the receivers of prescriptions, are Care 
Homes, requesting and collecting prescriptions on behalf of 
their residents. Among the dispensers, together with local 
small community pharmacies are larger organisations of 
pharmacy chains under the control of a multinational com-
pany, supermarket pharmacies, internet pharmacies, and dis-
pensing appliance contractors. There are also the interesting 
hybrids – dispensing doctors and prescribing pharmacists. All 
these stakeholders may adopt EPS2 compliant systems, but 
differently - depending on their prospects, hopes and fears - 
and with more or less choice in terms of software or autonomy 
in organising their work practices around EPS2.  
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Moving from a perspective of system users to the stakeholders 
involved in the implementation of EPS2, the map extends to 
the software suppliers (SW) that develop and provide prescrib-
ing and dispensing solutions to prescribers (SWpr) and dis-
pensers (SWd) respectively (Fig 2). Developers offer system 
compliant solutions responding to requirements presented by 
users, Connecting for Health, professional bodies and Royal 
Colleges. Prescribing and dispensing software solutions are 
different markets (and, usually, companies) in England and 
therefore we chose to present them in the map separately. The 
relatively simple map in figure 2 is rapidly revealed too re-
stricted to illustrate the number of stakeholders associated 
with EPS2 and who might be incorporated in an evaluation. 
 
 
 
Figure 2. Five stakeholders -  
implementers and users of EPS systems 
The delivery of EPS is a complex partnership between the 
Department of Health (DH), its agency Connecting for Health 
(CfH), the regional Strategic Health Authorities, the PCTs and 
dispensing and prescribing system suppliers. The role of CfH 
is to define standards, ensure these are adhered to, and to pro-
vide the infrastructure in order to support this service. The DH 
provides funding for community pharmacy to purchase EPS 
compliant systems (via PCTs) and also an ongoing allowance 
to pay for the maintenance of the required secure broadband 
connection. General practices also gain support for purchasing 
CfH accredited prescribing systems as part of their IT systems. 
Pharmacies and GP practices as independent contractors, how-
ever still make, at least in theory, the ultimate choice of which 
software to purchase and use.  
If we follow financial exchanges, more stakeholders enter the 
map. Financial exchanges in connection with EPS relate not 
only to the payment and reimbursement of prescribed medica-
tions and appliances, but also to payment and reimbursement 
for software and services, connection to secure network, pos-
sible financial incentives to use the service, potential sale and 
purchase of prescribing/dispensing data and marketing oppor-
tunities for pharmaceutical products/medical services. This 
indicates the potential of EPS2 to condition important changes 
in the business of community pharmacies. For instance, the 
rise of internet pharmacies, or the capture and use of prescrib-
ing and dispensing data for research purposes. Indeed, patient 
data and information governance is a sensitive aspect of EPS2. 
The design of this system will potentially allow a comprehen-
sive database of drug use (prescribing and dispensing) linkable 
to patient medical history. This could be incredibly valuable 
for research purposes and for medicine management, but also 
potentially subject to abuses and infringement of patient con-
fidentiality. An important stakeholder here may be the Infor-
mation Commissioner. 
Table 1. List of stakeholders  
(not comprehensive, in alphabetical order) 
AG Aggregators 
CP Community Pharmacies (independent and chain 
headquarters) 
CPst Community Pharmacy stores (dependent from 
chain management/headquarters) 
CP.pr Prescribing community pharmacists 
DAC  Dispensing Appliances Contractors 
D  Dispensers (including CP, DAC, IP, etc.) 
DH Department of Health  
DW Drug and Medication Wholesalers 
GP   General practitioners (family doctors) 
GPd Dispensing GP  
IMS IMS Health Pharmaceutical 
IP Internet Pharmacies 
IC Information Commissioner 
NPA The National Pharmacy Association  
NPSA National Patient Safety Agency 
NP Nurse prescribers 
P Patients (and carers) 
PCT  Primary Care Trusts 
Pr  Prescribers (including GP, NP, etc.) 
PSNC Pharmaceutical Services Negotiating Committee 
PS NHS Prescription Services 
RS Royal Societies 
SHA Strategic Health Authorities 
SUS  Secondary Use Service  
SW.gp Software supplier for GP 
SW.cp Software supplier for CP 
 
The above brief description of our attempt in map-making 
indicates the complexity found in the unfolding of interests 
that occur in the process of identifying stakeholders and repre-
senting their inter-relationships. Table 1 lists some (but not all, 
given space restrictions) of the stakeholders found to have a 
role or interest in EPS2 and Figure 3 illustrates examples of 
their interdependent relationships. The map can support fur-
ther investigation of transactional, financial, regulatory, or 
professional relationships. Of course the map is never com-
plete and never an exact illustration of all stakeholders and all 
their relationships. The drawbacks and the benefits of a map 
as a tool for analysis in evaluations are discussed below. 
Discussion – Map-Using 
The stakeholder map is intended to serve multiple purposes. It 
serves as an effective communication tool, used to elicit views 
and insights from interviewees by visualising presences and 
relationships. Over time and as it developed the map became a 
means to generate knowledge. By developing an object which 
could be shared and discussed between the various stakehold-
ers (and which each would recognise and be able to contribute 
to), we were making use of the map as ‘a boundary object’ [7]. 
Boundary objects are objects which allow the tacit difficult to 
Pr D 
P SWpr SWd 
express knowledge of one community to be expressed and 
shared by another community [8]. Through readers’ different 
interpretation of the map and through constant discussions, the 
map’s perceived gaps and ‘errors’ came to the fore, leading to 
further refinements and expansions, and allowing the interests 
and perspectives of stakeholders to be captured. This iterative 
process broadened our understanding of the meaning of EPS 
to different people and organisations. But to the extent that 
people differed on who was a stakeholder and how they fitted 
into the map, the challenge remained as to how to capture 
these multiple versions of reality.  
The strength of a map as a means to produce knowledge de-
rives from its three main features: mobility, stability and com-
binability [9]. The map is a mobile tool in the sense that it can 
be transferred between different people and organisations 
crossing boundaries. Using the map’s mobility we could 
communicate our understanding of stakeholders and their rela-
tionships among researchers as well as between researchers 
and participants/stakeholders. The map also embeds informa-
tion that is perceived as stable (relatively) when the map is 
transferred between people. In this way, information the map 
holds can resist distortions and misunderstandings that may 
emerge in any one place. Finally, the map is combinable be-
cause it enables further refinements and developments, inclu-
sion of new stakeholders and new relationships, or a drilling 
down into stakeholders in more detail, for example into the 
complex structure of a PCT. Mobility, stability and combina-
bility is what has allowed the map to develop from a simple 
three-stakeholder version (Figure 1) to the complex 28 stake-
holder version (Figure 3).  
The map reveals the complexity that surrounds EPS2 and the 
ways in which different stakeholders interrelate and contribute 
to it. However, the process of map-making is inevitably a pro-
cess of selection and omission of stakeholders or relationships. 
For instance, figure 1 represents the typical flow of a prescrip-
tion going from prescriber to patient and then to dispenser; 
however, some pharmacies provide a collection service which 
means that prescriptions go direct from prescriber to phar-
macy, bypassing the patient. This could be considered an ex-
ception to the usual scenario – whether (and how) exceptions 
are represented in the map is an open question. Exceptions, 
being on the one hand by definition unusual, but on the other, 
as boundary conditions, are key areas of interest to any analy-
sis. Map making is in other words both an intended and unin-
tended mode of simplification as complexity is synthesised 
into a comprehensible and sharable picture [10].  
A stakeholder map can only illustrate part of the ‘whole’ pic-
ture or one possible picture among many potentially to be 
drawn. This implies that a map is fundamentally political as it 
prioritises, accentuates and excludes stakeholders and their 
relationships, and embodies the worldviews of those who take 
part in its construction. As illustrated, our map started with 
three basic stakeholders who constituted our initial under-
standing of the ‘pragmatic’ view of EPS2. Through research 
we expanded the map in such a way so as to include additional 
stakeholders, who remained in the earlier version hidden. And 
there are many other potential stakeholders and relationships 
still to be discovered and presented. For that reason we would 
rather accept, in the spirit of Heisenberg and Schrödinger, that 
“Every new attempt to represent the world in a scientific for-
mulation, no matter how detailed and cumulative, will be 
swallowed up by the world expanding to contain it” [11]. In 
that way, a map is not only a means to generate knowledge but 
it is also a means to hinder and hide it. Furthermore, a static 2 
dimensional map in itself does not provide a rich account of 
the dynamic changing of relationships between stakeholders. 
Though, through layering of versions or digital animation a 
map may present or account for the historical development of 
stakeholder relationships, even if it cannot predict their future 
dynamics. 
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Figure 3 A more complex stakeholder map of EPS2  (a transaction flow of a patient’s e-prescription and a professional relationship  
between general practitioner/prescriber and community pharmacist/dispenser shown as examples.) 
Conclusion 
This paper discusses the strengths of map-making as a tool as 
well as the complexities and challenges surrounding a stake-
holder map in terms of map-making and map-using. We pres-
ent the iterative process of identifying stakeholders in the 
Electronic Prescription Service and some of the benefits and 
drawbacks of using a map as a methodological tool for data 
collection and analysis.  
The map shows strongly how implementation and adoption of 
systems in healthcare takes place in a distributed landscape. In 
relation to our research topic this implies that electronic 
transmission of prescriptions does not start with a prescribing 
authority and end with a dispensing authority. Rather the EPS 
draws in a great number of stakeholders who mediate between 
prescribing and dispensing, each of whom has distinctive in-
terests and a role in making this initiative work (or not). Un-
derstanding stakeholders and their interests as part of evaluat-
ing the adoption of EPS2, ultimately means capturing this 
distributed network of interests and relations.  
Our research has also illustrated the limitations of a map in 
analysing stakeholders. The map is not an exact re-
presentation of the prescribing and the dispensing scenario in 
all its detail (although when it is taken out of the context of the 
identification process - it may be interpreted and judged as 
such). Our map, as a tool to identify stakeholders and their 
interests, constitutes one among many possible re-
presentations of the world of prescribing and dispensing. Car-
tographers are well aware that maps are an outcome of a re-
ductionist activity that abstracts complexity from reality: 
“...mapping allows for an understanding of terrain as only the 
surface expression of a complex and dynamic imbroglio of 
social and natural processes” [12]. 
As our map-making and map-using research processes con-
tinue, we will investigate different variations of the stake-
holder map; we will depict, explore, compare and superim-
pose: stakeholders, boundaries, transactions, flows, move-
ments, and transformations of business models, connected 
with the introduction of electronic prescribing in primary care 
in England. We argue that a dynamic use of a stakeholder 
map, and a reflective map-making practice, has great potential 
to inform the analysis and evaluation of IT programmes in 
healthcare and beyond.  
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